Study Stopped
Mahnaz Kazemipoor has not handed over human subject review board approval letter to her colleague.
Effect of Consumption of Black Cumin (Nigella Sativa L.) Water Extract on Weight Loss in Overweight Women
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this clinical trial is to study the therapeutic effect of black cumin water extract (Nigella sativa L.) on obesity and overweight
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2011
CompletedFirst Posted
Study publicly available on registry
May 26, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedNovember 18, 2015
February 1, 2011
May 24, 2011
November 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
BP (blood pressure)
Change from Baseline in Systolic Blood Pressure at 12 weeks
0 and12 weeks
HR (heart rate)
Change from Baseline in heart rate at 12 weeks
0 and 12 weeks
Body water (percentage)
Change from Baseline in body water at 12 weeks
0 and 12 weeks
Fat free mass (percentage)
Change from Baseline in fat free mass at 12 weeks
0 and 12 weeks
Fat mass (percentage)
Change from Baseline in fat mass at 12 weeks
0 and 12 weeks
Bone mass
Change from Baseline in bone mass at 12 weeks
0 and 12 weeks
BMR (basic metabolic rate)
Change from Baseline in BMR at 12 weeks
0 and12 weeks
AMR (active metabolic rate)
Change from Baseline in AMR at 12 weeks
0 and 12 weeks
Secondary Outcomes (5)
BMI (body mass index)
0 and 12 weeks
WHR (waist to hip ratio)
0 and 12 weeks
MUAC (mid upper arm circumference)
0 and 12 weeks
Wrist circumference
0 and 12 weeks
Changes in appetite as measured by a 10-point visual analog scale (VAS)
0 and 12 weeks
Study Arms (2)
Water flavored placebo
PLACEBO COMPARATORto be given orally in a dosage of 30 ml trice daily for 60 days
Black cumin water extract as a traditional medicine
EXPERIMENTALBlack cumin water extract as a traditional medicine to be given orally in a dosage of 30 ml trice daily for 60 days
Interventions
to be given orally in a dosage of 30 ml trice daily for 60 days
Eligibility Criteria
You may qualify if:
- Being Obese
You may not qualify if:
- Having heart disease or renal disease
- using drugs influencing metabolism and appetite
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 24, 2011
First Posted
May 26, 2011
Study Completion
June 1, 2011
Last Updated
November 18, 2015
Record last verified: 2011-02